Extracellular Vesicle-Derived mir-148a-3p Promotes Plasmablast Differentiation in Bullous Pemphigoid via BACH2 Repression and mTOR Activation
Listen to this summary
This study aims to elucidate the molecular mechanisms behind plasmablast differentiation in bullous pemphigoid (BP), an autoimmune blistering disease. The authors found that extracellular vesicle-derived miR-148a-3p enhances plasmablast differentiation by repressing BACH2 and activating the mTOR signaling pathway, suggesting a novel regulatory mechanism in BP pathogenesis and highlighting miR-148a-3p as a potential diagnostic and therapeutic target.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from The Journal of investigative dermatology
View all →More in Dermatology
View all →Jun 24, 2026 · The New England journal of medicine
Prevention and Treatment of Peanut Allergy
Jun 24, 2026 · Lancet (London, England)
Efficacy and safety of tirofiban after successful endovascular reperfusion in acute ischaemic stroke (ATTRACTION) in China: a multicentre, double-blind, randomised controlled trial
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
Jun 24, 2026 · The New England journal of medicine
A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis
Jun 24, 2026 · The New England journal of medicine
Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas
Jun 23, 2026 · Lancet (London, England)
Non-invasive removal of the Smart tracheal occlusion device for fetal congenital diaphragmatic hernia: a single-arm, open-label, phase 1 study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


